GEORGEHUTTONGEORGE HUTTON0.000000000000000.000000000000002056HUTTON, GEORGEProfessorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAuthorship 83944Pharmaceutical Health Outcomes and PolicyAuthorship 1018792Authorship 145523Authorship 1602977Authorship 161192225546364Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Griffith LM, Muraro PA, Openshaw H, Sayre PH, St?ve O, Arnold DL, Spychala ME, McConville KC, Harris KM, Phippard D, Georges GE, Wundes A, Kraft GH, Bowen JDJAMA neurologyHigh-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report. JAMA Neurol. 2015 Feb; 72(2):159-69.JAMA Neurol2015-02-01T00:00:002015High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report.25876482Schurmann P, Basra S, Awar OG, Aguilar D, Basant A, Dragan E, Hutton GJ, Birnbaum YMultiple sclerosis and related disordersAbnormal rhythms in patients without known cardiac disease after a first dose of fingolimod. Mult Scler Relat Disord. 2014 May; 3(3):408-12.Mult Scler Relat Disord2013-11-28T00:00:002013Abnormal rhythms in patients without known cardiac disease after a first dose of fingolimod.Authorship 3165111Authorship 586755Authorship 9973917200 CAMBRIDGEHouston, 77030TXAuthorship 303992526052259Yapundich R, Applebee A, Bethoux F, Goldman MD, Hutton GJ, Mass M, Pardo G, Klingler M, Henney HR, Blight AR, Carrazana EJInternational journal of MS careEvaluation of Dalfampridine Extended Release 5 and 10 mg in Multiple Sclerosis: A Randomized Controlled Trial. Int J MS Care. 2015 May-Jun; 17(3):138-45.Int J MS Care2015-05-01T00:00:002015Evaluation of Dalfampridine Extended Release 5 and 10 mg in Multiple Sclerosis: A Randomized Controlled Trial.HOWARDWEINERHOWARD WEINER11403WEINER, HOWARDProfessor15596734Bakshi R, Hutton GJ, Miller JR, Radue EWNeurologyThe use of magnetic resonance imaging in the diagnosis and long-term management of multiple sclerosis. Neurology. 2004 Dec 14; 63(11 Suppl 5):S3-11.Neurology2004-12-14T00:00:002004The use of magnetic resonance imaging in the diagnosis and long-term management of multiple sclerosis.74Professor10Assistant Professor33Clinical Professor14Associate Professor2Adjunct Assistant Professor46Distinguished Emeritus ProfessorEVERTONEDMONDSONEVERTON EDMONDSON0.000000000000000.000000000000004842EDMONDSON, EVERTONProfessor12581542Zhang J, Hutton G, Zang YClinical therapeuticsA comparison of the mechanisms of action of interferon beta and glatiramer acetate in the treatment of multiple sclerosis. Clin Ther. 2002 Dec; 24(12):1998-2021.Clin Ther2002-12-01T00:00:002002A comparison of the mechanisms of action of interferon beta and glatiramer acetate in the treatment of multiple sclerosis.Authorship 327701527653865Mandel JJ, Goethe EA, Patel AJ, Heck K, Hutton GJJournal of the neurological sciencesNewly diagnosed ganglioglioma in an adult patient with multiple sclerosis. J Neurol Sci. 2016 Oct 15; 369:51-52.J Neurol Sci2016-07-12T00:00:002016Newly diagnosed ganglioglioma in an adult patient with multiple sclerosis.15223245Hong J, Zang YC, Hutton G, Rivera VM, Zhang JZJournal of neuroimmunologyGene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis. J Neuroimmunol. 2004 Jul; 152(1-2):126-39.J Neuroimmunol2004-07-01T00:00:002004Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis.18852359Su?rez Zambrano GA, Hutton GJArchives of neurologyHeart-shaped lesion secondary to neurosarcoidosis. Arch Neurol. 2008 Oct; 65(10):1388-9.Arch Neurol2008-10-01T00:00:002008Heart-shaped lesion secondary to neurosarcoidosis.14985264Sun W, Popat U, Hutton G, Zang YC, Krance R, Carrum G, Land GA, Heslop H, Brenner M, Zhang JZBrain : a journal of neurologyCharacteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis. Brain. 2004 May; 127(Pt 5):996-1008.Brain2004-02-25T00:00:002004Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis.15471364Zang YC, Skinner SM, Robinson RR, Li S, Rivera VM, Hutton GJ, Zhang JZMultiple sclerosis (Houndmills, Basingstoke, England)Regulation of differentiation and functional properties of monocytes and monocyte-derived dendritic cells by interferon beta in multiple sclerosis. Mult Scler. 2004 Oct; 10(5):499-506.Mult Scler2004-10-01T00:00:002004Regulation of differentiation and functional properties of monocytes and monocyte-derived dendritic cells by interferon beta in multiple sclerosis.15660513Zhang J, Hutton GAnnual review of medicineRole of magnetic resonance imaging and immunotherapy in treating multiple sclerosis. Annu Rev Med. 2005; 56:273-302.Annu Rev Med2005-01-01T00:00:002005Role of magnetic resonance imaging and immunotherapy in treating multiple sclerosis.17908695Nash RA, Stuve O, Bowen JD, Frohman EM, Griffith LM, Hutton GJ, Kraft GH, Popat U, Racke MK, Muraro PABrain : a journal of neurologyAutologous HSCT for advanced MS: is the glass half-empty or really half-full? Brain. 2008 Feb; 131(Pt 2):e89; author reply e90.Brain2007-09-30T00:00:002007Autologous HSCT for advanced MS: is the glass half-empty or really half-full?17401392Vu T, Carrum G, Hutton G, Heslop HE, Brenner MK, Kamble RBone marrow transplantationHuman herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2007 Jun; 39(11):705-9.Bone Marrow Transplant2007-04-02T00:00:002007Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation.18838462Lotze TE, Northrop JL, Hutton GJ, Ross B, Schiffman JS, Hunter JVPediatricsSpectrum of pediatric neuromyelitis optica. Pediatrics. 2008 Nov; 122(5):e1039-47.Pediatrics2008-10-06T00:00:002008Spectrum of pediatric neuromyelitis optica.Authorship 100883Authorship 702075228148635Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Steinmiller KC, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stuve O, Arnold DL, Wener MH, Georges GE, Wundes A, Kraft GH, Bowen JDNeurologyHigh-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS. Neurology. 2017 Feb 28; 88(9):842-852.Neurology2017-02-01T00:00:002017High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS.20874252Hong J, Hutton GJJournal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine ResearchRegulatory effects of interferon-? on osteopontin and interleukin-17 expression in multiple sclerosis. J Interferon Cytokine Res. 2010 Oct; 30(10):751-7.J Interferon Cytokine Res2010-10-01T00:00:002010Regulatory effects of interferon-? on osteopontin and interleukin-17 expression in multiple sclerosis.21152340Helekar SA, Shin JC, Mattson BJ, Bartley K, Stosic M, Saldana-King T, Montague PR, Hutton GJFrontiers in human neuroscienceFunctional brain network changes associated with maintenance of cognitive function in multiple sclerosis. Front Hum Neurosci. 2010; 4:219.Front Hum Neurosci2010-11-22T00:00:002010Functional brain network changes associated with maintenance of cognitive function in multiple sclerosis.18208877Cohen JA, Calabresi PA, Chakraborty S, Edwards KR, Eickenhorst T, Felton WL, Fisher E, Fox RJ, Goodman AD, Hara-Cleaver C, Hutton GJ, Imrey PB, Ivancic DM, Mandell BF, Perryman JE, Scott TF, Skaramagas TT, Zhang H, ACT InvestigatorsMultiple sclerosis (Houndmills, Basingstoke, England)Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data. Mult Scler. 2008 Apr; 14(3):370-82.Mult Scler2008-01-21T00:00:002008Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data.19036497Hutton GJ, Avila M, Suarez GAClinical neurology and neurosurgeryPneumocephalus after an epidural steroid injection. Clin Neurol Neurosurg. 2009 Apr; 111(3):309-10.Clin Neurol Neurosurg2008-11-25T00:00:002008Pneumocephalus after an epidural steroid injection.19204263Cohen JA, Imrey PB, Calabresi PA, Edwards KR, Eickenhorst T, Felton WL, Fisher E, Fox RJ, Goodman AD, Hara-Cleaver C, Hutton GJ, Mandell BF, Scott TF, Zhang H, Apperson-Hansen C, Beck GJ, Houghtaling PL, Karafa MT, Stadtler M, ACT InvestigatorsNeurologyResults of the Avonex Combination Trial (ACT) in relapsing-remitting MS. Neurology. 2009 Feb 10; 72(6):535-41.Neurology2009-02-10T00:00:002009Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS.21775738Stosic M, De Jesus P, McCarthy J, Hutton G, Rivera VNeurologyImmune thrombocytopenic purpura in a patient with multiple sclerosis treated with natalizumab. Neurology. 2011 Aug 02; 77(5):505-7.Neurology2011-07-20T00:00:002011Immune thrombocytopenic purpura in a patient with multiple sclerosis treated with natalizumab.22112394Chen M, Chen G, Deng S, Liu X, Hutton GJ, Hong JJournal of neuroimmunologyIFN-? induces the proliferation of CD4+CD25+Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis. J Neuroimmunol. 2012 Jan 18; 242(1-2):39-46.J Neuroimmunol2011-11-21T00:00:002011IFN-? induces the proliferation of CD4+CD25+Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessorD008590Disorders24240.967582MeningoencephalitisD020529Disorders14340.967059Multiple Sclerosis, Relapsing-RemittingFERNANDOCUASCUTFERNANDO CUASCUT14357CUASCUT, FERNANDOAssistant ProfessorD016919Disorders17250.962884Meningitis, CryptococcalD009103Disorders1243480.753802Multiple SclerosisD054019Disorders31340.960779Immune Reconstitution Inflammatory SyndromeAuthorship 936601230228838Yeo CJJ, Hutton GJ, Fung SHRadiology case reportsAdvanced neuroimaging in Balo's concentric sclerosis: MRI, MRS, DTI, and ASL perfusion imaging over 1 year. Radiol Case Rep. 2018 Oct; 13(5):1030-1035.Radiol Case Rep2018-06-01T00:00:002018Advanced neuroimaging in Balo's concentric sclerosis: MRI, MRS, DTI, and ASL perfusion imaging over 1 year.FARIHAJAMALFARIHA JAMAL0.000000000000000.000000000000005688JAMAL, FARIHAAssociate ProfessorDepartment of NeurologyDepartment of PediatricsDepartment of NeurosurgeryDepartment of UrologyUrologyNeurologyNeurosurgeryPediatrics-NeurologyBaylor College of MedicineUniversity of Houston College of PharmacyDORISKUNGDORIS KUNG0.000000000000000.000000000000001068KUNG, DORISAssociate Professor4.8820.00471096189research areas2.805610.015530421coauthor of32.50213.2596360similar to1148selected publicationsTIMOTHYLOTZETIMOTHY LOTZE29.70508570000000-95.401808700000002118LOTZE, TIMOTHYProfessorMICHAELNEWMARKMICHAEL NEWMARK0.000000000000000.000000000000003008NEWMARK, MICHAELClinical ProfessorVICTORRIVERAVICTOR RIVERA0.000000000000000.000000000000003455RIVERA, VICTORDistinguished Emeritus ProfessorVENEETHACHERIANVENEETHA CHERIAN0.000000000000000.000000000000004734CHERIAN, VENEETHAAssistant ProfessorRAJENDERAPARASURAJENDER R. APARASU29.70508570000000-95.401808700000004604APARASU, RAJENDERProfessorAuthorship 944889230935074Cuascut FX, Hutton GJBiomedicinesStem Cell-Based Therapies for Multiple Sclerosis: Current Perspectives. Biomedicines. 2019 Mar 30; 7(2).Biomedicines2019-03-30T00:00:002019Stem Cell-Based Therapies for Multiple Sclerosis: Current Perspectives.true1Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant ProfessorAuthorship 960911431715512Wang KY, Carlton J, Guffey D, Hutton GJ, Moron FEClinical imagingHistogram analysis of apparent diffusion coefficient and fluid-attenuated inversion recovery in discriminating between enhancing and nonenhancing lesions in multiple sclerosis. Clin Imaging. 2020 Jan; 59(1):13-20.Clin Imaging2019-09-12T00:00:002019Histogram analysis of apparent diffusion coefficient and fluid-attenuated inversion recovery in discriminating between enhancing and nonenhancing lesions in multiple sclerosis.Authorship 979203432171597Earla JR, Paranjpe R, Kachru N, Hutton GJ, Aparasu RRResearch in social & administrative pharmacy : RSAPUse of disease modifying agents in patients with multiple sclerosis: Analysis of ten years of national data. Res Social Adm Pharm. 2020 Dec; 16(12):1670-1676.Res Social Adm Pharm2020-03-11T00:00:002020Use of disease modifying agents in patients with multiple sclerosis: Analysis of ten years of national data.true1Clinical ProfessorClinical Professortrue1Distinguished Emeritus ProfessorDistinguished Emeritus ProfessorAuthorship 986172432231060Fisher KS, Cuascut FX, Rivera VM, Hutton GJBiomedicinesCurrent Advances in Pediatric Onset Multiple Sclerosis. Biomedicines. 2020 Mar 28; 8(4).Biomedicines2020-03-28T00:00:002020Current Advances in Pediatric Onset Multiple Sclerosis.Authorship 990371332463779Earla JR, Thornton JD, Hutton GJ, Aparasu RRJournal of managed care & specialty pharmacyMarginal Health Care Expenditure Burden Among U.S. Civilian Noninstitutionalized Individuals with Multiple Sclerosis: 2010-2015. J Manag Care Spec Pharm. 2020 Jun; 26(6):741-749.J Manag Care Spec Pharm2020-06-01T00:00:002020Marginal Health Care Expenditure Burden Among U.S. Civilian Noninstitutionalized Individuals with Multiple Sclerosis: 2010-2015.Authorship 991007732498033Oh J, Achiron A, Celius EG, Chambers C, Derwenskus J, Devonshire V, Hellwig K, Hutton GJ, McCombe P, Moore M, Rog D, Schneider JR, Simm RF, Sousa L, Vincent SG, Chung L, Daizadeh N, Mitchell C, Compston DAS, CAMMS223, CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ InvestigatorsMultiple sclerosis and related disordersPregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years. Mult Scler Relat Disord. 2020 Aug; 43:102146.Mult Scler Relat Disord2020-05-06T00:00:002020Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years.Authorship 993660232629400Earla JR, Hutton GJ, Thornton JD, Aparasu RRMultiple sclerosis and related disordersFactors Associated with Prescribing Oral Disease Modifying Agents in Multiple Sclerosis: a Real-world Analysis of Electronic Medical Records. Mult Scler Relat Disord. 2020 Oct; 45:102334.Mult Scler Relat Disord2020-06-24T00:00:002020Factors Associated with Prescribing Oral Disease Modifying Agents in Multiple Sclerosis: a Real-world Analysis of Electronic Medical Records.true1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessorAuthorship 1004901233177813Earla JR, Hutton GJ, Thornton JD, Chen H, Johnson ML, Aparasu RRPatient preference and adherenceComparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple Sclerosis. Patient Prefer Adherence. 2020; 14:2187-2199.Patient Prefer Adherence2020-11-04T00:00:002020Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple Sclerosis.Authorship 1006133533255552Mercado V, Dongarwar D, Fisher K, Salihu HM, Hutton GJ, Cuascut FXBiomedicinesMultiple Sclerosis in a Multi-Ethnic Population in Houston, Texas: A Retrospective Analysis. Biomedicines. 2020 Nov 25; 8(12).Biomedicines2020-11-25T00:00:002020Multiple Sclerosis in a Multi-Ethnic Population in Houston, Texas: A Retrospective Analysis.Authorship 1012485233641232Earla JR, Hutton GJ, Thornton DJ, Chen H, Johnson ML, Aparasu RRPharmacotherapyComparative treatment effectiveness of oral fingolimod and conventional injectable disease-modifying agents in multiple sclerosis. Pharmacotherapy. 2021 05; 41(5):440-450.Pharmacotherapy2021-03-18T00:00:002021Comparative treatment effectiveness of oral fingolimod and conventional injectable disease-modifying agents in multiple sclerosis.Authorship 10136505Authorship 1013680233711579Alkabie S, Castrodad-Molina R, Heck KA, Mandel J, Hutton GJMultiple sclerosis and related disordersThe concurrence of multiple sclerosis and glioblastoma. Mult Scler Relat Disord. 2021 May; 50:102877.Mult Scler Relat Disord2021-03-02T00:00:002021The concurrence of multiple sclerosis and glioblastoma.15385235Wyss K, Hutton G, N'Diekhor YAIDS careCosts attributable to AIDS at household level in Chad. AIDS Care. 2004 Oct; 16(7):808-16.AIDS Care2004-10-01T00:00:002004Costs attributable to AIDS at household level in Chad.Authorship 1021358334139459Cuascut FX, Alkabie S, Hutton GJMultiple sclerosis and related disordersFingolimod-related cryptococcal meningoencephalitis and immune reconstitution inflammatory syndrome in a patient with multiple sclerosis. Mult Scler Relat Disord. 2021 Aug; 53:103072.Mult Scler Relat Disord2021-06-05T00:00:002021Fingolimod-related cryptococcal meningoencephalitis and immune reconstitution inflammatory syndrome in a patient with multiple sclerosis.CARLOSPEREZCARLOS PEREZ16966PEREZ, CARLOSAssistant ProfessorAuthorship 1025681934284316Lee H, Nakamura K, Narayanan S, Brown RA, Nash RA, Griffith LM, Steinmiller KC, Devine SM, Hutton GJ, Popat U, Racke MK, Georges GE, Bowen JD, Arnold DLMultiple sclerosis and related disordersBrain volume change after high-dose immunosuppression and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis. Mult Scler Relat Disord. 2021 Sep; 54:103149.Mult Scler Relat Disord2021-07-12T00:00:002021Brain volume change after high-dose immunosuppression and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis.Authorship 1034447334799458Alkabie S, Tanweer O, Hutton GJ, Cuascut FXNeurologyClinical Reasoning: A 57-Year-Old Man With Stepwise Progressive Paraparesis, Sensory Loss, Urinary Retention, and Constipation. Neurology. 2022 02 01; 98(5):e555-e560.Neurology2021-11-19T00:00:002021Clinical Reasoning: A 57-Year-Old Man With Stepwise Progressive Paraparesis, Sensory Loss, Urinary Retention, and Constipation.Authorship 1187902Authorship 1037079335007821Choudhury NA, Castrodad-Molina RM, Hutton GJ, Cuascut FXMultiple sclerosis and related disordersElsberg syndrome following acute immunosuppressive treatment for multiple sclerosis relapse. Mult Scler Relat Disord. 2022 Feb; 58:103498.Mult Scler Relat Disord2022-01-04T00:00:002022Elsberg syndrome following acute immunosuppressive treatment for multiple sclerosis relapse.Authorship 10382324Authorship 1039884335278846Li J, Chikermane SG, Earla JR, Hutton GJ, Aparasu RRMultiple sclerosis and related disordersFACTORS ASSOCIATED WITH SWITCHING FROM INJECTABLE TO ORAL DISEASE MODIFYING AGENTS AMONG PATIENTS WITH MULTIPLE SCLEROSIS. Mult Scler Relat Disord. 2022 Apr; 60:103703.Mult Scler Relat Disord2022-02-26T00:00:002022FACTORS ASSOCIATED WITH SWITCHING FROM INJECTABLE TO ORAL DISEASE MODIFYING AGENTS AMONG PATIENTS WITH MULTIPLE SCLEROSIS.35158421Talwar A, Earla JR, Hutton GJ, Aparasu RRMultiple sclerosis and related disordersPrescribing of disease modifying agents in older adults with multiple sclerosis. Mult Scler Relat Disord. 2022 Jan; 57:103308.Mult Scler Relat Disord2021-10-05T00:00:002021Prescribing of disease modifying agents in older adults with multiple sclerosis.Authorship 1044627235481133Earla JR, Hutton GJ, Thornton JD, Chen H, Johnson ML, Aparasu RRExploratory research in clinical and social pharmacyFactors associated with oral fingolimod use over injectable disease- modifying agent use in multiple sclerosis. Explor Res Clin Soc Pharm. 2021 Jun; 2:100021.Explor Res Clin Soc Pharm2021-05-05T00:00:002021Factors associated with oral fingolimod use over injectable disease- modifying agent use in multiple sclerosis.true1Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant ProfessorKRISTENFISHERKRISTEN FISHER17885FISHER, KRISTENAssistant ProfessorAuthorship 1050858335839614Li J, Zakeri M, Hutton GJ, Aparasu RRMultiple sclerosis and related disordersHealth-related quality of life of patients with multiple sclerosis: Analysis of ten years of national data. Mult Scler Relat Disord. 2022 Oct; 66:104019.Mult Scler Relat Disord2022-07-05T00:00:002022Health-related quality of life of patients with multiple sclerosis: Analysis of ten years of national data.true1Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant ProfessorAuthorship 1056312336400561P?rez CA, Cuascut FX, Hutton GJNeurologic clinicsImmunopathogenesis, Diagnosis, and Treatment of Multiple Sclerosis: A Clinical Update. Neurol Clin. 2023 02; 41(1):87-106.Neurol Clin2022-10-31T00:00:002022Immunopathogenesis, Diagnosis, and Treatment of Multiple Sclerosis: A Clinical Update.true1Adjunct Assistant ProfessorAdjunct Assistant ProfessorAuthorship 10697063Authorship 1069798337189845Moore MZ, P?rez CA, Hutton GJ, Patel H, Cuascut FXBiomedicinesHealth Disparities in Multiple Sclerosis among Hispanic and Black Populations in the United States. Biomedicines. 2023 Apr 20; 11(4).Biomedicines2023-04-20T00:00:002023Health Disparities in Multiple Sclerosis among Hispanic and Black Populations in the United States.37157135Earla JR, Li J, Hutton GJ, Johnson ML, Aparasu RRPharmacotherapyComparative adherence trajectories of oral disease-modifying agents in multiple sclerosis. Pharmacotherapy. 2023 06; 43(6):473-484.Pharmacotherapy2023-05-22T00:00:002023Comparative adherence trajectories of oral disease-modifying agents in multiple sclerosis.Authorship 1077415337554927Li J, Huang Y, Hutton GJ, Aparasu RRExploratory research in clinical and social pharmacyAssessing treatment switch among patients with multiple sclerosis: A machine learning approach. Explor Res Clin Soc Pharm. 2023 Sep; 11:100307.Explor Res Clin Soc Pharm2023-07-10T00:00:002023Assessing treatment switch among patients with multiple sclerosis: A machine learning approach.Authorship 215263Authorship 426336Authorship 4540811Authorship 141470624453710Avila-Ornelas J, Avila M, Stosic M, Robles L, Prieto PG, Hutton GJ, Rivera VMInternational journal of MS careThe role of postpartum intravenous corticosteroids in the prevention of relapses in multiple sclerosis. Int J MS Care. 2011; 13(2):91-3.Int J MS Care2011-01-01T00:00:002011The role of postpartum intravenous corticosteroids in the prevention of relapses in multiple sclerosis.Authorship 405032Authorship 425882Authorship 521986JACOBMANDELJACOB MANDEL7894MANDEL, JACOBAssociate ProfessorAuthorship 870168Authorship 942381Authorship 776923ROSEKHAVARIROSE KHAVARI8171KHAVARI, ROSEAdjunct Assistant Professor